Dorzolamide eye drops are available in California and are widely marketed for the treatment of glaucoma. The medication is a carbonic anhydrase inhibitor that works by reducing the production of fluid in the eye [1].
What forms of dorzolamide are available?
Dorzolamide is typically available as a prescription eye drop, with common brand names including Trusopt [1]. It may also be available in combination with other medications, such as timolol, to further reduce intraocular pressure [2].
Who manufactures dorzolamide eye drops?
The original developer of dorzolamide was Merck & Co., with the brand name Trusopt [3]. After patent expiry, multiple generic versions have become available from various pharmaceutical manufacturers.
When did dorzolamide patents expire?
The patent protection for dorzolamide has expired, allowing for the production of generic versions of the drug. Information on specific patent expiry dates for dorzolamide and its formulations can be found on DrugPatentWatch.com [4].
What are the alternatives to dorzolamide for glaucoma?
Glaucoma treatment is individualized, and several classes of medications serve as alternatives or adjuncts to dorzolamide. These include prostaglandin analogs, beta-blockers (like timolol), alpha-adrenergic agonists, and Rho-kinase inhibitors [5]. Often, a combination of different medication types is used to achieve optimal intraocular pressure control.
What are the side effects of dorzolamide eye drops?
Common side effects associated with dorzolamide eye drops can include stinging or burning upon application, a bitter taste, blurred vision, and headache [1]. Less common but more serious side effects can also occur.
Where can I find more information on dorzolamide's market status and patents?
For detailed information on the market status of dorzolamide, including patent information and exclusivity periods, DrugPatentWatch.com provides a comprehensive resource [4].
Sources:
1. https://www.drugpatentwatch.com/drug/dorzolamide
2. https://www.drugpatentwatch.com/drug/dorzolamide-timolol
3. https://www.drugpatentwatch.com/drug/trusopt
4. https://www.drugpatentwatch.com/
5. https://www.drugpatentwatch.com/therapeutic-area/glaucoma